Vitrolife AB Stock Nasdaq Stockholm
Equities
SE0000816043
Medical Equipment, Supplies & Distribution
Sales 2024 * | 3.64B 333M | Sales 2025 * | 4.06B 372M | Capitalization | 22.16B 2.03B |
---|---|---|---|---|---|
Net income 2024 * | 530M 48.55M | Net income 2025 * | 677M 62.01M | EV / Sales 2024 * | 6.3 x |
Net Debt 2024 * | 762M 69.75M | Net cash position 2025 * | 304M 27.89M | EV / Sales 2025 * | 5.39 x |
P/E ratio 2024 * |
41.8
x | P/E ratio 2025 * |
32.8
x | Employees | - |
Yield 2024 * |
0.82% | Yield 2025 * |
0.85% | Free-Float | 55.39% |
Latest transcript on Vitrolife AB
Managers | Title | Age | Since |
---|---|---|---|
Bronwyn Brophy
CEO | Chief Executive Officer | - | 23-07-31 |
Patrik Tolf
DFI | Director of Finance/CFO | 54 | 21-12-31 |
Chairman | 68 | 15-05-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 53 | 19-05-01 | |
Chairman | 68 | 15-05-06 | |
Director/Board Member | 64 | 18-04-26 |
1st Jan change | Capi. | |
---|---|---|
-1.04% | 12.47B | |
-17.29% | 6.99B | |
-2.21% | 5.1B | |
+2.92% | 4.27B | |
-4.79% | 4.27B | |
-50.07% | 3.45B | |
+7.65% | 2.61B | |
-3.34% | 1.67B | |
-13.66% | 1.48B |